Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Claudia Maria Barth
Observed names:
C Barth,
Claudia Barth,
Claudia M. Barth
Institution:
B. Braun (Germany)
Observed institution:
B. Braun (Germany)
ORCID:
0009-0009-3458-2575
Observed ORCID:
0009-0009-3458-2575
OpenAlex ID:
A5034645164
A health economic evaluation of the multinational, randomized controlled CONVINCE trial: cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysis
2025
·
Aniek E.M. Schouten
, Felix Fischer
, et al.
·
Kidney International
·
26
PDF
Psychosocial Determinants for Self-Reported Health Status in Patients on Hemodialysis: A Cohort Analysis of the CONVINCE Randomized Trial
2024
·
Krister Cromm
, Le Hong Ngoc Pham
, et al.
·
Kidney360
·
5
Characteristics of Populations Included in Randomized Controlled Trials of Hemodiafiltration and Registry Real-Life Populations: A Systematic Review
2025
·
Krister Cromm
, Ngoc Pham
, et al.
·
Clinical Journal of the American Society of Nephrology
·
3
CO155 Metal Needles Versus Plastic Cannulae in Hemodialysis Patients: A Cost-Benefit Analysis
2024
·
P Ghosh
, S Ahmed
, et al.
·
Value in Health
·
1
PDF
Patient-Reported Outcomes with High-Volume Hemodiafiltration Versus High-Flux Hemodialysis Across Clinical Subgroups: Results from the CONVINCE Trial
2026
·
Krister Cromm
, Felix Fischer
, et al.
·
Clinical Journal of the American Society of Nephrology
Convective Volume, Body Size, and Mortality in Hemodiafiltration: An Individual Patient Data Analysis of Randomized Trials
2026
·
Krister Cromm
, Robin W.m. Vernooij
, et al.
·
Journal of the American Society of Nephrology
Measurement Precision Matters: Patient-Reported Outcomes Measurement Information System Preference (PROPr) Score Detects Treatment Effects Missed by EQ-5D-5L in the CONVINCE Randomized Trial
2026
·
Christoph Paul Klapproth
, Krister Cromm
, et al.
·
Journal of the American Society of Nephrology
Hemodiafiltration: Clinical Practice of Today and a Look into the Future
2026
·
Peter J. Blankestijn
, Sanne Roos
, et al.
·
Journal of the American Society of Nephrology
Wcn26-2809 Convective Volume, Patient Anthropometric Characteristics and Risk of All-cause Mortality in Hemodiafiltration: a Cohort Study
2026
·
Krister Cromm
, Robin W. Vernooij
, et al.
·
Kidney International Reports
#3210 Health status in different subgroups of people receiving hemodiafiltration versus hemodialysis for renal replacement therapy: a subgroup analysis of the CONVINCE randomized controlled trial
2025
·
Felix Fischer
, Krister Cromm
, et al.
·
Nephrology Dialysis Transplantation
Convective Volume, Patient Anthropometric Characteristics, and Risk of All-Cause Mortality in Hemodiafiltration: A Cohort Study
2025
·
Krister Cromm
, Robin W.m. Vernooij
, et al.
·
Journal of the American Society of Nephrology
EE54 Polihexanide and Betaine (PSGX) Containing Solution Versus Saline for the Treatment of Leg Ulcers: A Comparative Cost Analysis Using Real-World Data From England
2024
·
F Gansen
, C Hepworth
, et al.
·
Value in Health
PDF
Exploratory Post Hoc Analysis of the CONVINCE Randomized Controlled Trial: Differential Treatment Effects of Hemodiafiltration (HDF) and Hemodialysis (HD) on Quality of Life
2024
·
Krister Cromm
, Felix Fischer
, et al.
·
Journal of the American Society of Nephrology
Cost Utility of High-Dose Online Hemodiafiltration Compared with High-Flux Hemodialysis: Economic Evaluation of the Multinational, Randomized Controlled CONVINCE Trial
2024
·
Aniek E.M. Schouten
, Felix Fischer
, et al.
·
Journal of the American Society of Nephrology
Patient-Reported Health Status of Adults with Kidney Failure Receiving Hemodiafiltration vs. Hemodialysis: Results from the CONVINCE Randomized Controlled Clinical Trial
2023
·
Matthias Rose
, Felix Fischer
, et al.
·
Journal of the American Society of Nephrology
Show more works
View as search
Works count:
15
Citation count:
35
H-index:
3
I10-index:
1
Year
Topic
Type
